Lung Cancer Trial, Not Yet Recruiting NCT07079072 Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT07079072
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have a history of lung cancer and have finished their initial treatment (such as surgery, radiation, or chemotherapy) at least 8 weeks ago.
  • People aged between 18 and 75 years old.
  • People who have been diagnosed with fatigue related to their cancer.
  • People whose doctors estimate they are likely to survive for at least 3 months.
  • People who have moderate to severe cancer-related fatigue, based on a score of 4 or higher on a specific fatigue questionnaire (the Chinese version of the Brief Fatigue Inventory).
  • People whose general physical functioning falls within a certain range, as measured by a standard medical scoring tool called the ECOG Performance Status (scores 0 to 2) (confirm with trial site).
  • People who are willing to join the study and have signed a consent form agreeing to take part.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who had significant fatigue before being diagnosed with lung cancer.
  • People who have severe anxiety or depression.
  • People who show notable difficulties with memory or thinking, or who have suicidal tendencies.
  • People who have a history of an underactive thyroid (hypothyroidism) or chronic fatigue syndrome.
  • People who have moderate to severe anaemia, meaning their haemoglobin level is below 90 g/L.
  • People who are experiencing severe pain, rated 7 or higher on a standard 0–10 pain scale.
  • People who have serious sleep disorders.
  • People who have severe malnutrition.
  • People whose physical functioning is seriously reduced.
  • People who have received acupuncture treatment for cancer-related fatigue within the past month.
  • People who have serious uncontrolled health conditions, such as heart failure, recent heart attack, unstable chest pain, hormonal disorders, digestive problems, neurological conditions, severe infections, liver or kidney failure, or severe chronic lung disease.
  • People who are unlikely to follow the study requirements consistently (confirm with trial site).
  • People who are breastfeeding, pregnant, or planning to become pregnant within the next four months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Phone: +8618811189057

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
30 September 2026

Primary endpoints

The proportion of patients whose score of average fatigue over the past 24 hours decreased by at least 2 points on the Brief Fatigue Inventory-Chinese (BFI-C) compared to baseline.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov